TARGETING MS4A3 TO TREAT CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

$149,875FY2022Defense Health AgencyDOD

Versiti Blood Health, Inc., Milwaukee WI

Investigators

View source on USAspending →